Benzodiazepines consumption may have increased during the COVID-19 pandemic.

Mattiuzzi, Camilla; Sanchis-Gomar, Fabian; Lippi, Giuseppe

Mattiuzzi, Camilla; Sanchis-Gomar, Fabian; Lippi, Giuseppe.

Mattiuzzi C; Section of Clinical Biochemistry and School of Medicine, University of Verona, Italy.
Sanchis-Gomar F; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Lippi G; Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy. Electronic address: giuseppe.lippi@univr.it.

J Affect Disord ; 314: 124-125, 2022 10 01.

Article in English | MEDLINE | ID: covidwho-1926590

Subject(s)

COVID-19; Benzodiazepines/adverse effects; Humans; Pandemics; SARS-CoV-2

Keywords

Benzodiazepines; COVID-19; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Affect Disord Year: 2022 Document Type: Article Affiliation country: J.jad.2022.07.017

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google